MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction

Phillip H. Kuo, Ali Abu-Alfa, Richard Bucala, Jason Griffith, Kacie Carlson, Michael Girardi, Jeffrey Weinreb, Shawn Cowper

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

In the last 3 years, revelations linking gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) have had a tremendous impact on the utilization of enhanced magnetic resonance imaging (MRI) in patients with kidney disease. Virtually unknown to the radiology community prior to 2006, NSF has generated significant concern and confusion among radiologists, clinicians and patients.

Original languageEnglish (US)
Pages (from-to)22-33
Number of pages12
JournalApplied Radiology
Volume38
Issue number4
StatePublished - Apr 1 2009

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction'. Together they form a unique fingerprint.

  • Cite this

    Kuo, P. H., Abu-Alfa, A., Bucala, R., Griffith, J., Carlson, K., Girardi, M., Weinreb, J., & Cowper, S. (2009). MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction. Applied Radiology, 38(4), 22-33.